Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism RF Walker, NA Zakai, RF MacLehose, LT Cowan, TJ Adam, A Alonso, ... JAMA internal medicine 180 (2), 190-197, 2020 | 135 | 2020 |
Branching and merging: an investigation into current version control practices S Phillips, J Sillito, R Walker Proceedings of the 4th International Workshop on Cooperative and Human …, 2011 | 80 | 2011 |
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: trends from 2012 to 2017 PL Lutsey, RF Walker, RF MacLehose, A Alonso, TJ Adam, NA Zakai Research and practice in thrombosis and haemostasis 3 (4), 668-673, 2019 | 78 | 2019 |
Vagus nerve stimulation as a potential therapy in early Alzheimer’s disease: A review M Vargas-Caballero, H Warming, R Walker, C Holmes, G Cruickshank, ... Frontiers in human neuroscience 16, 866434, 2022 | 58 | 2022 |
Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism PL Lutsey, NA Zakai, RF MacLehose, FL Norby, RF Walker, NS Roetker, ... British journal of haematology 185 (5), 903-911, 2019 | 38 | 2019 |
Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer‐associated venous thromboembolism NA Zakai, RF Walker, RF MacLehose, TJ Adam, A Alonso, PL Lutsey Journal of Thrombosis and Haemostasis 16 (12), 2403-2412, 2018 | 26 | 2018 |
Venous thrombosis risk during and after medical and surgical hospitalizations: the medical inpatient thrombosis and hemostasis (MITH) study XJ Bruno, I Koh, PL Lutsey, RF Walker, NS Roetker, K Wilkinson, ... Journal of Thrombosis and Haemostasis 20 (7), 1645-1652, 2022 | 23 | 2022 |
Inpatient versus outpatient acute venous thromboembolism management: trends and postacute healthcare utilization from 2011 to 2018 PL Lutsey, RF Walker, RF MacLehose, FL Norby, LH Evensen, A Alonso, ... Journal of the American Heart Association 10 (20), e020428, 2021 | 19 | 2021 |
Direct oral anticoagulants and warfarin for atrial fibrillation treatment: rural and urban trends in Medicare beneficiaries FL Norby, PL Lutsey, ND Shippee, LY Chen, C Henning-Smith, A Alonso, ... American Journal of Cardiovascular Drugs, 1-11, 2022 | 14 | 2022 |
Simulation verifies advantages of multiple fracs in horizontal well RF Walker, E Ehrl, M Arasteh Oil and Gas Journal;(United States) 91 (48), 1993 | 13 | 1993 |
Incidence and risk factors of pulmonary hypertension after venous thromboembolism: an analysis of a large health care database PL Lutsey, LH Evensen, T Thenappan, KW Prins, RF Walker, JF Farley, ... Journal of the American Heart Association 11 (14), e024358, 2022 | 12 | 2022 |
Venous thromboembolism mortality and trends in older US adults, 2011–2019 K Giorgio, RF Walker, RF MacLehose, D Adrianzen‐Herrera, W Wang, ... American journal of hematology 98 (9), 1364-1373, 2023 | 9 | 2023 |
Effect of chronic digoxin use on mortality and heart failure hospitalization in pulmonary arterial hypertension KY Chang, K Giorgio, K Schmitz, RF Walker, KW Prins, MR Pritzker, ... Journal of the American Heart Association 12 (6), e027559, 2023 | 8 | 2023 |
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism. JAMA Intern Med. 2019 RF Walker, NA Zakai, RF MacLehose, LT Cowan, TJ Adam, A Alonso | 6 | 2019 |
Autoimmune disease and risk of postpartum venous thromboembolism RF Walker, NA Zakai, SM Mason, RF MacLehose, FL Norby, LH Evensen, ... Research and practice in thrombosis and haemostasis 7 (2), 100091, 2023 | 5 | 2023 |
SGLT2 inhibitors are associated with reduced cardiovascular disease in patients with type 2 diabetes: an analysis of real-world data W Wang, LY Chen, RF Walker, LS Chow, FL Norby, A Alonso, JS Pankow, ... Mayo Clinic Proceedings 98 (7), 985-996, 2023 | 4 | 2023 |
Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis NA Zakai, RF Walker, RF MacLehose, I Koh, A Alonso, PL Lutsey Research and Practice in Thrombosis and Haemostasis 5 (6), e12575, 2021 | 4 | 2021 |
Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding RF MacLehose, NA Zakai, RF Walker, A Alonso, T Adams, PL Lutsey Research and Practice in Thrombosis and Haemostasis 5 (4), e12514, 2021 | 4 | 2021 |
Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis D Adrianzen-Herrera, PL Lutsey, K Giorgio, RF Walker, NA Zakai Research and Practice in Thrombosis and Haemostasis 7 (1), 100024, 2023 | 3 | 2023 |
Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism PL Lutsey, RF MacLehose, JNS Claxton, RF Walker, TJ Adam, A Alonso, ... Vascular Medicine 25 (6), 549-556, 2020 | 3 | 2020 |